OR WAIT null SECS
- Advertise
- About Us
- Editorial Board
- Contact Us
- Job Board
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Infection Control Today. All rights reserved.
SurgiLance Awarded Three-Year Contract by UK's NHSpasa
SurgiLance announces that it has been awarded a three-year contract under the national framework agreement to supply its One-Step safety lancets to the NHS in England. The contract period runs from April 2004 to March 2007 and establishes SurgiLance as a significant player within the UK's safety lancet market.
Stephen Yi, SurgiLance's vice president in Europe says, "This is a big breakthrough for SurgiLance and it puts the One-Step firmly on the UK map."
The NHS Purchasing and Supply Agency, which awarded the contract, is an executive agency of the UK's Department of Health. The agency contracts on a national basis for products and services which are vital to the NHS as a whole. NHS PASA is progressively working to spread information regarding sharps and needlestick injury prevention in cooperation with relevant and interested organizations.
Among its many roles, the NHS PASA negotiates national contracts on behalf of the NHS in England. In this capacity, it works with approximately 400 NHS trusts. It manages hundreds of purchasing contracts which account for a huge proportion of the millions spent by the National Health Service on purchasing goods and services in the health service.
SurgiLance's One-Step line of safety lancets is now available to all NHS hospitals as an approved solution for preventing needlestick injuries suffered by NHS healthcare workers and patients.
"We are naturally very excited and thankful for this wonderful opportunity to become an approved supplier to the NHS PASA" Yi says.
SurgiLance designs, manufactures and sells safety medical devices that protect healthcare professionals from sharps injury. SurgiLance's One-Step safety lancet, which was introduced to the U.S. market in September 2000, achieved sales in excess of $6.3 million during 2003, a 106 percent increase over the 2002 sales of $3.1 million. The One-Step's unique pre-armed capability makes it extremely simple to use. It is available with either a needle or blade, each with different depths of penetration, to provide optimal blood flow for various applications and skin types.
Source: SurgiLance
